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In vivo protein kinases A and G (PKA and PKG) coordinately
phosphorylate a broad range of substrates to mediate their var-
ious physiological effects. The functions of many of these sub-
strates have yet to be defined genetically. Herein we show a role
for smoothelin-likeprotein 1 (SMTNL1), a novel in vivo target of
PKG/PKA, in mediating vascular adaptations to exercise. Aor-
tas from smtnl1/mice exhibited strikingly enhanced vasore-
laxation before exercise, similar in extent to that achieved after
endurance training of wild-type littermates. Additionally, con-
tractile responses to -adrenergic agonists were greatly attenu-
ated. Immunological studies showed SMTNL1 is expressed in
smooth muscle and type 2a striated muscle fibers. Consistent
with a role in adaptations to exercise, smtnl1/ mice also
exhibited increased type 2a fibers before training andbetter per-
formance after forced endurance training compared smtnl1/
mice. Furthermore, exercise was found to reduce expression of
SMTNL1, particularly in female mice. In both muscle types,
SMTNL1 is phosphorylated at Ser-301 in response to adrenergic
signals. In vitro SMTNL1 suppresses myosin phosphatase activ-
ity through a substrate-directed effect, which is relieved by Ser-
301 phosphorylation. Our findings suggest roles for SMTNL1 in
cGMP/cAMP-mediated adaptations to exercise through mech-
anisms involving direct modulation of contractile activity.
The contractile state of smooth muscle (SM)2 is largely gov-
erned by phosphorylation of myosin regulatory light chain
(LC20), which in turn is regulated by the opposing activities of
myosin light chain kinase (MLCK) and myosin phosphatase,
SMPP1M (1). In SM, both MLCK and SMPP1M are regulated,
thereby enabling homeostatic control of contractile activity (2).
Exquisite control is necessary because of the essential roles of
SM in many physiological processes, such as maintenance of
blood pressure. In most SMs, release of cyclic nucleotides
(cGMP/cAMP), in response to hormonal or neuronal stimula-
tion, promote relaxation either by lowering intracellular [Ca2]
or desensitizing themuscle toCa2 by inhibitingMLCKand/or
activating SMPP1M (2).
Targeted deletions of both PKA and PKG in mice produce
profound phenotypes, underscoring the importance of these
kinases in many physiological processes (3, 4). In vivo, both
kinases are known to selectively target a discrete number of
substrates and current thinking suggests that selective targeting
is themeans bywhich these broadly acting enzymes bring about
coordinated physiological responses (5). A few groups have
begun to test this hypothesis by selectively deleting PKA/PKG
targets in mice. Schlossmann et al. (6) demonstrated a major
role for IRAG (inositol 1,4,5-trisphosphate receptor 1 IP3R1-
associated protein, with exon 12 deleted by removing the 1,4,5-
trisphosphate receptor binding domain) in PKG-mediated reg-
ulation of [Ca2] in SM. Disruption of IRAG resulted in a
selective loss of signaling response. Other PKG/PKA-mediated
responses were largely intact, contrasting with deletion of PKG
itself, which produced profound loss of most cGMP/PKG-de-
pendent signaling.
Smoothelin-like protein 1 (SMTNL1, NP_077192) is an early
target of PKG in SM and is phosphorylated in vitro by PKG and
PKAat Ser-301 (7). TheC terminus contains a highly conserved
calponin homology (CH) domain (residues 342–459), also
found in the smoothelin family of smooth muscle-specific pro-
teins, whereas the N-terminal domain (residues 1–341) is com-
posed of entirely unique sequence. Studies in permeabilized SM
suggested a role in mediating Ca2 desensitization in response
to cGMP (7). To determine the physiological relevance of
SMTNL1 in mediating cGMP/cAMP signaling in vivo, we gen-
erated smtnl1/mice. We show that smtnl1/mice have an
exercised adapted phenotype, exhibiting better exercise per-
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formance and improved vasorelaxation/contractile responses
compared with WT littermates. In addition we also show dis-
crete expression of SMTNL1 to type 2a striated muscle fibers.
In skeletal muscle (SKM), exercise activates a large set of
muscle-specific genes leading to phenotypic changes such as
2b-to-2a fiber type switching, angiogenesis, and enhanced
mitochondrial biogenesis, improvingmetabolic function, blood
flow, and contractility (8, 9). PKA/PKG-dependent signaling
pathways have been implicated as primary messengers in exer-
cise adaptation in both SM and SKM (9–11). Our findings with
smtnl1/mice suggest the physiological role of the protein is
to mediate the actions of PKA/PKG in promoting adaptive
responses to exercise in SM, and possibly SKM. In biochemical
studies in vitro, purified SMTNL1 inhibits SMPP1M activity in
its dephosphorylated state, and this effect is alleviated by phos-
phorylation at Ser-301 by PKA or PKG. In both intact isolated
smooth and striated muscle Ser-301 is phosphorylated in
response to agonists that elevate intracellular cAMP or cGMP.
Collectively these findings suggest a potential mechanism by
which adrenergic signals can promote exercise-induced adap-
tations through regulation of myosin phosphatase activity.
EXPERIMENTAL PROCEDURES
Targeted Deletion of the Mouse smtnl1 Gene—The
smtnl1/ mouse was created using standard protocols.
Genomic DNA fragments were synthesized by high fidelity
PCR from the smtnl1 locus and cloned into a gene targeting
vector (OSfrtloxP) (supplemental Fig. S1A). The vector was
electroporated into an ES cell line derived from strain 129P2/
ola (E14Tg2a). Colonies were screened by PCR using a neomy-
cin-specific primer (NeoPro: 5-acgcgtcaccttaatatgc-3) and a
reverse primer outside the 3 arm of homology (5-gatgtgtgctc-
cttccctgagctgtctg-3). PCR-positive colonies were expanded
and re-screened by Southern hybridization. The probe detects
an 8.7-kb fragment in the WT locus and a 5.4-kb band in the
targeted locus when genomic DNA is cut with Nde1 (supple-
mental Fig. S1B). Targeted cloneswere injected into blastocysts
derived from strain C75BL/6(B6). Male chimeras demonstrat-
ing gene transmission were crossed with 129S6/SvEvTac(129)
females, and heterozygous offspring from that cross were back-
crossed over 9 generations to a 129 background. Mice were
genotyped using a multiplex PCR reaction with three primers:
NeoPro, acgcgtcaccttaatatgc; smtnlWT, ttcacctttgaccc; and
smtnl1Rev, caaaagagacctggc (supplemental Fig. S1C).
Immunohistochemistry and Indirect Immunofluorescent Fiber
Typing—Formalin (10%)-fixed, paraffin-embeddedmouse tissues
and timed embryos were analyzed by immunohistochemistry
using anti-SMTNL1 (Proteintech Inc.). Fiber typing by immun-
ofluorescent fiber typing was performed as described (12).
Soleus (SOL) and plantaris (PL) muscles were harvested and
frozen in liquid N2-cooled isopentane. Frozen cross-sections (8
m) were immunostained against MHC I, 2a, and 2b, dystro-
phin, and SMTNL1. Longitudinal sections were immuno-
stained with anti-myomesin (clone B4), and F-actin was visual-
ized with phalloidin-Alexa488.
Treadmill Exercise Protocol—8-week-old 129 mice were
maintained on a 12-h light/dark cycle. Mice exposed to the
treadmill but not exercise comprised the sedentary (SED)
group, those that ran on the treadmill were the exercise (EX)
group.Mice were exercised 3 h into their dark cycle on a 2-lane
enclosed treadmill. The treadmill stress and endurance proto-
cols were performed as described (13).Mice were acclimated to
the treadmill at 5 m/min at an 8° incline for 10 min for 2 days
before testing. For baseline and final stress tests, an incremental
protocol was used: 8.5 m/min, 0° incline, 9 min; then the speed
increased by 2.5m/min every 3min to amaximumof 40m/min
and incline increase 5° every 9 min to a maximum of 15°. Time
to fatigue was determined when mice could not maintain suffi-
cient speed to remain off the shock grid for 15 s. This test was
repeated twice with a 48-h rest between tests for each mouse
before and after a 5-week endurance training protocol, and
results were averaged. Performance was determined through
calculation of time to fatigue (minutes), distance run (inmeters,
calculated from run time and speed of treadmill), and vertical
work performed (kgm). Vertical workwas calculated as a prod-
uct of body weight (kilograms) and vertical distance (meters).
Mice were euthanized 24 h after the final stress test, and tissues
and serum were collected.
Isometric Force Measurements in Aortic Rings—Descending
thoracic aortas from SED and EX mice were placed in Krebs
solution, continuously aerated with 95% O2/5% CO2, at 37 °C.
Aortic rings (3 mm) were mounted in a wire myograph as
described previously (14). Passive stretch was set to 15 mil-
linewtons to simulate the wall tension generated by 100mmHg
of blood pressure. After 30 min of equilibration, 3 cycles of
constriction to phenylephrine (PE) were completed, followed
by a dose-response curve to PE. Aortic rings were precon-
stricted with PE, and dose-response curves to acetylcholine
(ACh) were determined.
Western Blot of Ser-301 Phosphorylation in Vivo—The spec-
ificity of the pSMTNL1S301 antibody (Proteintech, Inc.) was
tested against recombinant (rSMTLN1) and S301A SMTLN1
(rS301A) phosphorylated with purified PKA as described
before (7). To test Ser-301 phosphorylation in vivo byWestern,
isolated aortas held under tension (15 millinewtons), with
pinned bladder and SOL equilibrated in Krebs as described
(15), were stimulated with vehicle, ISO, or 8-bromo-cAMP
and snap frozen. Lysates were Western blotted with
anti-pSMTNL1S301.
Assay of SMPP1M—SMPP1M and SMmyosin were purified
from pig bladder as described (16). The purified myosin was
phosphorylated with rZIPK to 1.4 mol using the following
conditions; 1.0 ml of 2 mg/ml myosin (SM or SKM), 10 g of
rZIPK (truncated at Ser-276), 200MATP, 5mMMgCl2, 50mM
Tris-HCl for 30 min (22 °C), followed by dialysis against 50 mM
Tris-HCl, pH7.4, 1 mM dithiothreitol. Phosphatase assays were
performed as described (16). For experiments examining the
effects of SMTNL1 on SMPP1M activity in vitro, 2 mg of
purified rSMTNL1 was phosphorylated to stoichiometry with
purified PKA as described before (7). Direct phosphorylation
site analysis confirmed exclusive phosphorylation of Ser-301.
RESULTS
Disruption of the smtnl1 Gene—Genotyping of targetedmice
by PCR and Southern hybridization confirmed gene deletion
(supplemental Fig. S1, A–C). Deletion of SMTNL1 at the pro-
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tein level was confirmed by Western analysis of SKM extracts
(Fig. 1A). Basal activity, litter sizes, and embryonic develop-
ment of the smtnl1/mice were normal. Extensive histologi-
cal analysis of various blood vessels and general tissues showed
these to be normal in smtnl1/ mice. Additionally, electron
microscopy of SKM sections showed the muscle ultrastructure
was normal (supplemental Fig. S2). Western analysis of a bat-
tery of tissues showed SMTNL1 expression to be highest in
SKM relative to SM and other tissues (Fig. 1B). Within individ-
ual striated muscles, SMTNL1 is significantly more expressed
in SOL compared with PL or white vastus (WV), suggesting the
protein is preferentially expressed inmuscles containing Type I
or Type 2a fibers (Fig. 1C).
Histological Examination of WT, smtnl1/ Mice and
Human SKM Shows Exclusive Expression of SMTNL1 in Type
2a Fibers—Immunohistochemical analysis of SKM and heart
showed strong staining in the mixed fiber muscle PL (Fig. 2, A
and B) but was absent in sections of fast twitch type 2b muscle
WVand the oxidative type I/b heartmuscle (Fig. 2,C andD). To
determine the specific fiber type expressing SMTNL1, sections
from SOL and PL muscles were examined by immunofluores-
cent fiber typing confocal microscopy. Fig. 2 (E–L) shows
FIGURE 1.Analysis of SMTNL1 expression in smtnl1/ andWTmice. In
A, Western analysis of gastrocnemius muscle (GA) isolated from WT,
smtnl1/, and smtnl1/ confirms deletion of SMTNL1 in null mice and
an approximate 50% reduction in expression at the protein level in het-
erozygous (/) animals. B, representative Western analysis of levels of
SMTNL1 expression between tissues. The indicated tissues were isolated
from WT male mice and blotted for either SMTNL1 or Rho-GDI (loading
control). C, a representative Western analysis of the expression of SMTNL1
in soleus (SOL), plantaris (PL), and white vastus (WV) muscles. Expression
levels were quantified by densitometry, and levels in PL and WV were
compared with SOL using -actin as a loading control (n  6  S.D.)
(**, p  0.01; ***, p  0.001).
FIGURE 2. SMTNL1 is expressed in type 2a fibers in mice and humans. In A and B the mixed fiber muscle plantaris (PL) was isolated fromWTmice and
prepared for immunohistochemical analysis using the SMTNL1 antibody. Discrete SMTNL1 expression was observed in some fibers and not others. The
figure shows a muscle cross-section at low (A) and high (B) magnifications. In C and D, immunohistochemical analysis of white vastus and heart showed
no SMTNL1 staining (scale  100 m). E–H, show the results of fiber typing experiments carried by immunofluorescence with antibodies to myosin
heavy chains (MHC) I and 2a and SMTNL1 of cross-sections of soleus (SOL) and (I–L) plantaris muscle. The merged figures show specific localization of
SMTNL1 in type 2A fibers only in both muscle types. In the 10 panels comprising M and N, SMTNL1 expression was measured in vastus lateralis from
youngmen before (M) and after (N) training. Themerged images show that in humans SMTNL1 is expressed in type 2a fibers also and induced following
training. Color Key: In immunohistochemical experiments in A–D SMTNL1 is stained brown; in E–N MHC I is stained blue, MHC 2a is stained red, and
SMTNL1 is green.
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SMTNL1 staining co-localized with MHC-2A fibers in SOL
and PL, with no staining in MHC-1, MHC-2B, or MHC-2x/d
fibers. Specificity of staining was confirmed by competition
with rSMTNL1 and analysis of SKM from smtnl1/ mice
(supplemental Fig. S3). Longitudinal sections of SKM stained
with phalloidin and anti-myomesin showed that SMTLN1 is
specifically localized to the I-band andM-line, but absent in the
Z-line (supplemental Fig. S4). Immunohistochemical analysis
of timed embryos demonstrated SMTNL1 expression in axial
SKM beginning at day E14.5 (supplemental Fig. S5). To verify
relevance to human physiology, frozen sections of vastus late-
ralis biopsy from a study of young men pre and post 8 weeks of
stationary bicycle training were evaluated by immunofluores-
cent fiber typing for SMTNL1 expression and fiber typing. Fig.
2 (M andN) shows expression of SMTNL1 is specific to type 2a
fibers in humans. We are currently investigating whether exer-
cise alters the SMTNL1 expression levels in human.
Male smtnl1/ Mice Perform Better Than WT in Exercise
Stress Test after Endurance Training—Given the role of type 2a
fibers in endurance exercise adaptation and the finding that
SMTNL1 is only expressed in those fibers within SKM of both
mice and men, we investigated the exercise performance of
smtnl1/ mice. Fig. 3 shows all mice demonstrated similar
performance at the beginning of the study. All EX mice ran the
same time and distance during the endurance portion of the
training, but subjectively, the smtnl1/ mice demonstrated
more willingness to run and required fewer motivational stim-
uli, such as air puffs, throughout the 5-week protocol. Forty-
eight hours after the end of exercise training, the mice were
subjected to two more graded stress tests. Results of the stress
tests showed female EX smtnl1/ mice did not differ signifi-
cantly from the female EX WT mice: (time to fatigue: WT
24.6 0.8min baseline, 33.1 1.0min final; smtnl1/ 24.2
1.2 min baseline, 35.6  1.1 min final). However, male EX
smtnl1/mice showed significantly increased time to fatigue,
distance run, and vertical work performed compared withmale
EXWTmice after training (Fig. 3, A–C).
Endothelium-dependent Vasorelaxation of the Aorta Is
Enhanced, and Responses to -Adrenergic Constriction Are
Reduced in smtnl1/ Mice—Endurance training is known
to improve vascular performance. To investigate the impact
of SMTNL1 deletion on the contractile properties of
SM, isolated aorta from SED and EX mice were mounted
for isometric force measurement. To test NO-mediated,
endothelium-dependent vasorelaxation, dose-response curves
to ACh were generated. Aortas from SED smtnl1/ mice
showed significantly greater relaxation to ACh compared
with WT littermates (Fig. 4, A–D). The extent of relaxation
in smtnl1/ was similar to that from EX WT mice. There-
fore exercise did not improve relaxation in aortic rings from
smtnl1/ mice beyond that achieved in ACh-treated EX
WTmice (Fig. 4, E and F). These findings show that deletion
of SMTNL1 improves vascular responsiveness to ACh,
suggesting a role in cGMP/PKG-dependent vascular adapta-
tions to exercise. To determine if the improvements in vas-
cular relaxation were due to alteration in endothelial nitric-
oxide synthase expression or phosphorylation, we also
evaluated these parameters in WT and smtnl1/ aorta
lysates byWestern blot. However, no differences in endothe-
lial nitric-oxide synthase phosphorylation or expression
were observed.
To investigate the effects of SMTNL1 deletion on contractile
activity in response to exercise, aortic rings were stimulated
with increasing doses of PE. Fig. 4 (G and I) shows thatWTSED
and EX males generated greater isometric force per cross-sec-
tion area at doses above 1 M PE when compared with
smtnl1/ males in the same exercise category. In the case of
SED or EX smtnl1/ mice, the differences in force cannot be
attributed to decreased sensitivity to PE. Comparison of EC50 in
response to PE values with respect to isometric force develop-
ment in both aortas from WT and smtnl1/ did not show
significant differences. These findings suggest that the absence
of SMTNL1 does not result in receptor desensitization due to
either reduced expression of-adrenergic receptors or through
compensatory signaling mechanisms that down-regulate
receptor activity. In female mice, the differences in isometric
force generated in response to PE between SED or EXWT and
smtnl1/ were less significant (Fig. 4, H and J). This may be
reflective of expression levels of SMTNL1 between sexes. Gen-
erally, Western analysis of tissues expressing SMTNL1 showed
30–40% less expression in females relative to males (supple-
mental Fig. S6). As a result, SED WT female mice may already
be closer to smtnl1/males with respect to their responsive-
ness to -adrenergic agonists.
No effect on relaxation or force development was
observed in tracheal rings isolated from SED or EX, WT or
smtnl1/ mice. These findings are consistent with immu-
noblot Western data showing that SMTNL1 is not expressed
in airway SM (data not shown). Other vessels expressing
SMTNL1 have yet to be evaluated.
Deletion of SMTNL1 Induces Fiber Adaptations in SKM—To
determine if deletion of SMTNL1 significantly altered the pro-
portion type 2a fibers in a manner similar to that induced by
exercise, we first evaluated SKM fiber adaptation by immuno-
histochemical approaches. As reported by others, in all exam-
ined fibers fromWTmice, the percentage of 2a fibers increased,
whereas, the percentage of 2b fibers decreased in response to
endurance exercise (Fig. 5A). Interestingly, as determine by
fiber typing, SED smtnl1/ mice had the same percentage of
FIGURE 3. smtnl1/ mice perform better in exercise stress tests. Mice
were exercised, trained, and tested for endurance as described under “Exper-
imental Procedures.” In A, mean time to fatigue was measured. In B the total
mean distance run until fatigue was determined. In C, vertical work per-
formed in a graded exercise test was determined by increasing the gradient
of the treadmill. Data shown are frommaleWT and smtnl1/mice before (0
weeks) and after (5 weeks) forced treadmill endurance training; *, p  0.05
(n 5 S.D.). Results were similar in female mice, but less significant.
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2a fibers as EXWTmice, suggesting SED smtnl1/mice have
more type 2A fibers at baseline (Table 1). Although, the per-
centage of 2a fibers did not increase further in EX smtnl1/
mice. Like Ex mice, SED smtnl1/ mice showed significantly
lower level of type1b fibers, implying an adaptive response had
occurred. The numbers of type 1 and type 2x/d fibers were
unaffectedwith respect to genotype or exercise status (Table 1).
The finding that SED smtnl1/ mice exhibit fiber adapta-
tions as well as perform better in exercise suggests that exercise
may reduce SMTNL1 expression in vivo. Consistent with this
hypothesis, Western analysis of SOL isolated from EX mice
showed a significant reduction in expression of the protein in
male and femalemice (Fig. 5B). Similar trends were observed in
SM, although the extent of the change was not statistically sig-
nificant. These results indicate that improvements in exercise
performance in smtnl1/mice are likely to be either related to
improved blood flow due to adaptations within the vascular
smooth muscle, and/or, alterations in pathways directly regu-
lating contractile activity.
In addition to demonstrating changes in MHC2a and MH2b
expression in fiber typing experiments, we also examined other
knownmarkers of exercise adaptation byWestern blot, including
themitochondrialmarkersPGC-1 andCOX1VbyWesternblot.
Although, as shown by others, these markers were induced by
exercise, no differences were observed between SED smtnl1/
mice and SEDWT littermates (supplemental Fig. S7A).
Body andMuscle Weight, Capillary Contacts, Glucose Toler-
ance, Serum Chemistry Values, PL Muscle Time to Fatigue in
smtnl1/ and WT Mice—Other potential compensatory
mechanisms that could explain the smtnl1/ phenotype were
also evaluated, including overnight fasted glucose levels, resting
blood pressure (supplemental Fig. S7, B and C) serum muscle
enzyme activities (creatine kinase, aspartate aminotransferase,
and lactate dehydrogenase), total Ca, Mg, P, Na, K, Cl, and
albumin levels. All values were within normal ranges with no
differences between groups. Body and muscle weight were also
not different (supplemental Table S1). We asked whether cap-
illary density was altered in the smtnl1/mice. Capillary con-
tacts increased in type 2A fibers with exercise as expected, but
there was no difference betweenWTand smtnl1/mice (sup-
plemental Fig. S8A). Evaluation of time to fatigue of PL muscle
after tetanic stimulation in smtnl1/ and WT mice showed
similar times to fatigue of 20s (supplemental Fig. S8B).
Because SKM consists of mixed fibers (e.g. PL, 30% type 2a;
SOL, 40%) more complete assessment of the effects of
FIGURE 4. Deletion of SMTNL1 mimics exercise induced adaptations in
aorta. A and B show that deletion of SMTNL1 (smtnl1/) results in greater
sensitivity to acetylcholine (ACh) in aortas isolated from sedentary (Sed) male
(A) and female (B) mice, following precontraction with 3 M phenylephrine
(PE). C and D show that exercise (Ex) training improves sensitivity to ACh-
induced relaxation in wild0type (WT) male (C) and female (D) mice. In E and F,
the relaxant effects of AChwere compared in aortas isolated from Ex and Sed
male (E) and female (F) smtnl1/ mice and compared in the same experi-
mentwith aorta isolated from ExWT littermates. The figure shows that aortas
from Sed smtnl1/mice have the same sensitivity to ACh as aortas isolated
from Ex trained animals. The figures also show that deletion of SMTNL1 does
not enhance Ex-induced relaxation performance beyond that achieved by Ex
alone. In G–J, the effects of the contractile agonist PE on force development
were examined in aortas isolatedWT and smtnl1/male and femalemice Ex
and Sed mice. The figure shows that Ex attenuates force in WTmice, but this
effect is significantly enhanced in smtnl1/ mice. In all cases forces were
normalized to aorta cross-sectional area. (n  5  S.D.) (*, p  0.05; **, p 
0.01; and ***, p 0.001).
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SMTNL1 deletion on contractile activity in SKM will require
studies on isolated 2a fibers.
SMTNL1 Phosphorylation Is Regulated in SM and SKM in
Vivo—Previously, using a phosphoproteomic approach, we
identified SMTNL1 as an early target of PKG activation follow-
ing addition of 8-bromo-cGMP to permeabilized ileal smooth
muscle (7). In vitro, using rSMTNL1, we showed that the pro-
tein is an excellent substrate for both PKG and PKA. Both pro-
tein kinases phosphorylate SMTNL1 at a single site, Ser-301.
To determine if SMTNL1 is phosphorylated in intact smooth
muscles, we generated phosphospecific antibodies to Ser-301.
Specificity of the antibody was confirmed by Western blotting
againstWT rSMTNL1 and a recombinant S301Amutant of the
protein (rSMTNL1S301A) following in vitro phosphorylation of
the protein with purified PKA. Fig. 6A shows the antibody spe-
cifically recognizes only the phosphorylated formof the protein
and not the non-phosphorylated form or rSMTNL1S301A. Hav-
ing demonstrated specificity for the phospho-Ser-301 in vitro,
we examined phosphorylation in vivo. Isolated intact aortas
held under tension were treated with physiological concentra-
tions of norepinephrine, isoproterenol (ISO), acetylcholine,
8-bromo-cGMP, and 8-bromo-cAMP for times observed to
produced maximal relaxation as determined in Fig. 4. The
treated vessels were immediately frozen in liquid nitrogen. Tis-
sue extracts were blotted for Ser-301 phosphorylation. Fig. 6B
shows that all five agonists produce robust phosphorylation of
Ser-301, demonstrating that in aorta SMTNL1 is regulated
by cyclic nucleotide-dependent pathways activated by both
endothelial-dependent (ACh) and -independent pathways
(norepinephrine and ISO). Significantly, maximal phosphoryl-
ation of Ser-301was found to correlatewithmaximal relaxation
of aorta in response to ACh as observed in Fig. 4. Similar results
were also observed in studies with isolated bladder treated with
8-bromo-cGMP (data not shown). To test whether SMTNL1 is
phosphorylated in striated muscle, isolated SOL held under
tension were treated with ISO over the indicated time course
and fixed time point then frozen in liquid nitrogen, and extracts
were blotted for Ser-301 phosphorylation (Fig. 6, C andD). Fig.
6 (C and D) shows that SMTNL1 is robustly phosphorylated in
striated muscle and therefore likely to be directly regulated by
PKA in this tissue.
SMTNL1 Inhibits SMPP1M Activity toward Myosin through
a Substrate-directed Effect That Is Alleviated by Ser-301
Phosphorylation—The finding that exercise reduces SMTNL1
expression in SMand SKM, aswell as the finding that Ser-301 is
phosphorylated in vivo in response to both endothelial depend-
FIGURE 5. SMTNL1 deletion mimics exercise induced fiber adaptation in
SKM.A, representative immunofluorescenceconfocalmicroscopyof fiber typing
in plantarus ofWT (/) and smtnl1/mice before and after exercise training.
SMTNL1 is stained green, type2a fibers are red, type 1 fibers blue, and Type 2x/d
fibers are unstained. B, Western blot analysis shows exercise reduces SMTNL1
expression in striatedmuscle isolated frommale and femalemice. Between SED
and EX, the differences are significant in both males and females (n 7 S.E.
*, p 0.029). For quantitative analysis of fiber types shown in A see Table 1.
TABLE 1
SMTNL1 deletion induces type 2A fibers and reduces type 2B fibers to a similar extent to that observed in exercised mice
The table shows the results of fiber typing experimentsmeasuring the effects of EX and SMTNL1deletion on the expression ofmyosin heavy chains in plantarismuscle. Data
show the percentage of type I, type 2A, type 2B, and type 2x/d fibers. 300 fibers were counted from 5 animals per group and compared with each other.
MHC-1 MHC-2A MHC-2B MHC-2x/d
Sed Ex Sed Ex Sed Ex Sed Ex
%
smtnl1/ 1.9 1.6 0.8 0.2 26.5 1.1 37.9 2.0a 54.4 2.6 36.5 2.6b 17.3 1.4 21.6 1.1
smtnl1/ 1.4 0.6 1.6 0.4 34.3 1.8c 36.8 1.5 44 2.9d 39.6 3.0 22.0 1.5 22.4 1.1
a p 0.001 versusWT Sed 2a.
b p 0.001 versusWT Sed 2b.
c p 0.01 versusWT Sed 2a.
dp 0.05 versusWT Sed.
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ent agonists as well -adrenergic agonists, suggests a role in the
regulation of contraction. This hypothesis is supported by ear-
lier studies from our laboratory demonstrating an effect of
rSMTNL1 on Ca2-desensitization pathways when added to
permeabilized SM (7).Myosin light chain kinase (MLCK),myo-
sin, and myosin phosphatase (SMPP1M) have all been directly
implicated in mediating Ca2 desensitization in SM (1–3). The
phosphorylated form of SMTNL1 was generated by phospho-
rylating rSMTNL1 to 1 mol/mol with purified PKA as
described (7). Phosphopeptide sequence and phospho amino
acid analysis confirmed that PKAphosphorylated SMTNL1 at a
single site of Ser-301 (Fig. 7, A and B). To investigate whether
phosphoS301rSMTNL1 or SMTNL1 directly regulate MLCK
activity toward myosin, both forms of the protein were incu-
bated with the kinase at increasing concentrations in the pres-
ence of MgATP. No effects on MLCK activity were observed
even at the highest [SMTNL1] tested (30M) (data not shown).
To examine the effect of SMTNL1 onmyosin, we examined the
effects of the recombinant phospho and dephospho forms on
ATPase activity. Neither phospho nor dephospho-rSMTNL1
altered myosin ATPase activity under any conditions tested.
Additionally, no effect was observed, with either form of
rSMTNL1, on the rate atwhich SMmyosinwas phosphorylated
by a non-Ca2/calmodulin-dependent myosin kinase, such as
Zipper-interacting protein kinase. Finally, as shown previously
by our laboratory with dephospho-SMTNL1, the phosphoryla-
ted form of rSMTNL1 did not disrupt the ability of purified
myosin to bind and release actin in the presence of ATP (7).
Because neither ATPase activity nor the ability of myosin to
be phosphorylated were affected by the presence of rSMTNL1,
next we examined the effects of the phospho and dephospho
forms on SMPP1M activity toward myosin. Fig. 7C shows that
addition of the dephospho-rSMTNL1 had an inhibitory effect
of SMPP1M activity toward SM myosin. In contrast the phos-
phorylated form of SMTNL1 showed significantly reduced
inhibition of SMPP1M activity. Full-length SMTNL1 was
required to inhibit SMPP1Mactivity. Incubationwith truncated
formsof rSMTNL1(SMTNL11–346 andrSMTNL1346–452)hadno
effect upon SMPP1M activity (data not shown). Importantly,
32P-labeled rSMTNL1 itself was poorly dephosphorylated by
SMPP1M, in contrast to the catalytic subunits of PP1C or PP2A
(data not shown).
Interestingly, neither phosphorylated form of rSMTNL1 had
any effect on SMPP1M activity when LC20 was used as the sub-
strate. The differences in SMPP1M activity toward whole myosin
and LC20 suggest that SMTNL1 exerts a substrate directed effect
onmyosin itself, altering its accessibility to thephosphatase.These
in vitro findings may in part explain the smtnl1/ exercised
adapted phenotype observed in aorta, in which greater relaxation
is achieved in response toACh, and contractile force is suppressed
in response to PE. Loss of SMTNL1 relieves any inhibitory effect
that the protein may have on dephosphorylation of myosin by
FIGURE6.SMTNL1phosphorylation is regulated in vivo. InA, rSMTNL1 and
rSMTNL1S301A were phosphorylated with purified PKA as described under
“Experimental Procedures.” Reactions were stopped at the indicated times,
and phosphorylation of Ser-301 was detected with the Ser-301 phospho-
specific antibody. The figure illustrates the specificity of the antibody for the
phosphorylated form of SMTNL1. In B, isolated aortas were held under ten-
sion and treated with the indicated agonists for 5min. The vessels were snap
frozen in liquid nitrogen, and extracts were blotted for Ser-301 phosphoryla-
tion. The extent of phosphorylationwas determined by densitometry. Repre-
sentative Western blots are shown WT  smtnl/ aorta; KO  smtnl1/
aorta. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a
loading control (n 5 S.E. *, p 0.05). InC, soleusmuscleswere held under
tension and treated for the indicated times with either vehicle (VEH) or 10M
isoproterenol (ISO). The muscles were snap frozen with liquid nitrogen, and
extracts were blotted for Ser-301 phosphorylation. In D, soleus muscles were
treated for 5 min with 10M ISO, snap frozen with liquid nitrogen, and phos-
phorylation of Ser-301 was quantitated by Western blotting using total
SNTNL1 (tSMTNL1) as the loading control (n 6 S.E.; **, p 0.01).
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SMPP1M. By these criteria, the exercise-induced improve-
ments in vascular performance could also be attributed to
reduced expression of SMTNL1 in this tissue and possibly
SKM. The finding that Ser-301 phosphorylation also relieves
the inhibitory effect of SMTNL1 on SMPP1M in vitro suggests
one potential in vivo mechanism of action whereby PKG (and
PKA) can regulate myosin phosphorylation through phospho-
rylation of SMTNL1, in addition to exercise-induced alter-
ations in the level of its expression.
DISCUSSION
We have examined the physiological relevance of SMTNL1,
a novel in vivo target of PKG/PKA previously identified in SM
proteomically (7). The physiological role of the protein was not
obvious from the primary sequence alone.Although the protein
has a highly conserved calponin homology domain (CH
domain) in its C terminus, two-thirds of the remaining N-ter-
minal sequence is entirely unique within themouse and human
genomes. Preliminary CD analysis and NMR studies with
N-terminal domain indicate the structure is disordered.3
Therefore, to determine SMTNL1 function, herein, we gener-
ated smtnl1/ mice. Studies with smtnl1/ mice in a 129
congenic background strongly suggest SMTLN1 plays a role in
PKG/PKA-mediated adaptation to exercise. First, isolated SED
smtnl1/ aortas exhibit relaxation/contraction responses that
are similar to those observed in aortal rings isolated from WT
littermates subjected to 5 weeks of exercise training. Second,
overall smtnl1/ mice perform better in exercise compared
with WT littermates. Third, in immunohistochemical studies
we found SMTNL1 is exclusively expressedwithin type 2a SKM
fibers in both mice and humans, and that SED smtnl1/mice
have the same levels of type 2a fibers andMHC2a expression as
EXWT mice. Fourth, exercise training reduces the expression
of SMTNL1 in SM and SKM. Collectively, these findings sug-
gest common roles for the protein in adaptations to exercise in
SKM as well as SM.
Based on studies with purified SMPP1M and recombinant
SMTNL1, a potential mechanism by which SMTNL1may pro-
mote muscle adaptations is through regulation of contractile
activity. In vitro, in its dephosphorylated state, SMTNL1
reduces SMPP1M activity, whereas phosphorylation at Ser-301
blocks this effect. These in vitro findings may provide a poten-
tial mechanism to explain the smtnl1/ phenotype as well as
suggest a function for the protein in vivo. If SMTNL1 suppress
SMPP1M activity, its absence would result in higher rates of
myosin dephosphorylation. This suggests that SMTNL1’s nor-
mal role in SM is to act as a physiological break on contractile
activity, which is alleviated through Ser-301 phosphorylation.
Additionally, the finding that exercise itself reduces expression
of SMTNL1 provides an additional longer term mechanism of
regulation in which myosin dephosphorylation would be con-
stantly favored over phosphorylation by increasing endogenous
SMPP1M activity. Thus, receptor-mediated pathways can
acutely regulate SMTNL1 function through Ser-301 phospho-
rylation, whereas exercise achieves the same effect by reducing
its expression. As indicated in in vitro biochemical experi-
ments, the molecular mechanism by which SMTNL1 alters
SMPP1Mactivity appears to be through interactionswithmyo-
sin itself rather than the phosphatase itself i.e. SMTNL1 alters
myosins ability to be dephosphorylated by SMPP1M. This con-
clusion is supported by the finding that SMTNL1 had no appar-
ent effect on SMPP1M activity when recombinant light chains
were used as the substrate. The single CH domain on SMTNL1
is the most likely primary site of myosin binding. The sequence
of the remaining two thirds of the protein predicts a disordered
structure, suggesting it may fold around myosin. The Ser-301
site borders the CHdomain, suggesting phosphorylationwould
interrupt interactions with myosin.
3 T. Haystead, unpublished observations.
FIGURE 7. SMTNL1 regulates SMPP1M activity toward myosin. In
A, rSMTNL1 was phosphorylated with purified PKA (n  3; S.E.). In B,
phosphorylation of Ser-301 was confirmed by phospho amino acid anal-
ysis and cleaved radioactive peptide analysis as described (7). In C,
SMPP1M activity was measured against 32P-labeled SM myosin (‚) and
rLC20 (E) with or without phospho-SMTNL (filled) or dephospho-SMTNL1
(open). Purified SM myosin and recombinant SM LC20 were phosphoryla-
ted with purified SKM MLCK as described (16) (*, p  0.001 n  3; S.E.).
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The changes observed in smtnl1/mice beg the question as
to howaprotein acting onmyosin dephosphorylation can affect
exercise induced adaptation in SM, and possibly SKM? In SM,
multiple adaptations occur in response to physical exercise
(10). The physical forces of increased shear stress, transmural
pressure, and cyclic stretch are major stimuli. Various kinase
signal transduction pathways are activated such as those medi-
ated by PKA and PKG, Akt kinase, phosphatidylinositol 3-ki-
nase, MLCK, and mitogen-activated protein kinase (10, 19).
Therefore one explanation is that SMTNL1 provides a phar-
maco-mechanical mechanism to initiate adaptations in
response to elevations in cGMP/cAMP. Alterations in the sen-
sitivity of SM muscles to Ca2 through activation of myosin
phosphatase and myosin dephosphorylation would have a pro-
found effect on contraction/relaxation rates, and in SKM
mechanical activity is itself a primarymediator of adaptive fiber
switching (20). Alternatively, SMTNL1 could have additional
roles as a direct transcriptional regulator of adaptive responses
in muscle.
The interesting observation by immunohistochemistry
and immunofluorescence that SKM from smtnl1/ show
increased type 2a fibers without exercise training suggests a
direct role in SKM fiber adaptation process. The adaptive
effect was not complete. Whereas type 2a fibers and MHC2a
expression increase and type 2b fibers and MHC2b expres-
sion decrease by SMTNL1 deletion, other known exercise-
induced proteins were unaffected. Other groups however,
have demonstrated that individual proteins associated with
exercise-induced adaptations can be divorced from one
another in SKM (17). Themechanisms that promoteMHC2a
expression in smtnl1/ mice could either be related to
improved blood flow to the muscle as a result of the vascular
adaptations mimicking the increased blood flow that occurs
during exercise, or, as a result of a mechanical effect from
alterations in contractile activity as a result loss of the effects
on myosin phosphatase activity. Although phosphorylation
of SKMmyosin is not required for contractile activity, it does
induce Ca2 sensitization in SKM (21). Also, -adrenergic
signaling, which leads to activation of cAMP/PKA in SKM, is
part of the contractile and adaptive responses to exercise and
is essential for energy metabolism through its glycogenolytic
effects (11).
Exercise-induced adaptations in both SM and SKM are
generally recognized as having long term health benefits in
humans. Our data suggest that suppression of SMTNL1
expression can promote these adaptations fully in SM, and at
least in part in SKM, without the necessity of prolonged
exercise training. The finding that exercise itself reduces
SMTNL1 expression, clearly demonstrates that expression
of the protein is highly regulated. As shown herein, Western
analysis of various tissues shows different levels of expres-
sion of SMTNL1 between SM types. Therefore, different lev-
els of SMTNL1 expression may contribute to differences in
contractile responses between SM types. We also observed
different levels of SMTNL1 expression between the genders.
Generally, male mice have about twice the amount of
SMTNL1 compared with females, suggesting expression is
regulated by sex hormones. In humans and mice, the physi-
cal differences between male and female SKM are well doc-
umented, and generally premenopausal females exhibit
lower blood pressure and are less prone to development of
hypertension than males. Therefore, understanding the
pathways that regulate SMTNL1 expression in SM and SKM
may provide new therapeutic strategies to treat a variety of
diseases associated with cardiovasculature.
Finally, although SMTNL1 shares homology with the
smoothelin family of SM-specific proteins within its CH
domain, the smtnl1/ mouse has a very distinct phenotype
from the smoothelin-deleted mouse. Targeted deletion of
smoothelinA andBproduced profound alterations in intestinal
smooth muscle, including intestinal fragility, SM hypertrophy,
and altered contractility (18). In contrast, smtnl1/mice have
no alterations in SM architecture and appear normal on the
surface. These findings clearly discriminate SMTNL1 function-
ally from the smoothelin family. Originally, our laboratories
named SMTNL1 as CHASM, for calponin homology activated
in smooth muscle. The protein was recently renamed Smooth-
elin-like protein 1 by the international committee governing
gene ontology based on sequence alignments within the CH
domain of SMTNL1. However we believe that, because the
smtnl1/ mice and smoothelin/ mice have such distinct
phenotypes, the SMTNL1 nomenclature may be misleading.
Additionally, SMTNL1, unlike smoothelins, is also expressed in
striated muscle and not exclusively in smooth muscles. Our
original acronym, CHASM, may therefore be a more appropri-
ate description of the protein.
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